RankingsLogo

Moderna, Inc.

Moderna, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Moderna, Inc. is a pharmaceutical and biotechnology company that uses mRNA science to create medicines and vaccines that help the immune system protect against disease. Its research addresses how to protect people from infectious diseases, cancer, autoimmune conditions, and more.

Ticker: MRNA

Humankind Value: $48.7 B

Revenue: $3.2 B

Market Cap: $10.7 B

Badge100_2025
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Moderna, Inc. creates positive Humankind Value on the whole. Considerable positive value is associated with Pharmaceuticals ($29.9 B), Healthcare R&D ($14.5 B), and Economic Value ($3.9 B). Positive value from Pharmaceuticals and Healthcare R&D is linked to an estimate of 850,000 additional years lived by people worldwide. Downsides for this company are associated with Greenhouse Gases (-$660.1 M) and Air Pollution (-$71.8 M). Pharmaceuticals, Healthcare R&D, Economic Value, Greenhouse Gases, and Air Pollution impacts are attached to this company as a result of its direct business activities.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings